http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-056471-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| filingDate | 2006-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-056471-A1 |
| titleOfInvention | BAZEDOXIFEN ACETATE FORMULATIONS |
| abstract | This is directed to bazedodoxifene acetate formulations that have reduced polymorphic conversion, to compositions containing them, to their preparations and their uses. Claim 1: A pharmaceutical composition characterized in that it comprises a pharmaceutically effective amount of bazedoxifene acetate and a vehicle or excipient system, wherein the vehicle or excipient system comprises: a) a first filler / diluent component that constitutes about 5% a about 85% by weight of the pharmaceutical formulation; b) a second optional filler / diluent component constituting from about 5% to about 85% by weight of the pharmaceutical formulation; c) an optional antioxidant component that constitutes up to about 15% by weight of the pharmaceutical formulation; d) a sliding / disintegrating agent component constituting from about 0.01% to about 10% by weight of the pharmaceutical formulation; and e) a lubricating component that constitutes from about 0.01% to about 10% by weight of the pharmaceutical formulation. Claim 29: A tablet characterized in that it comprises a composition according to any one of claims 1 to 28. Claim 31: A capsule characterized in that it contains a composition according to any of claims 1 to 28. Claim 32: A non-aqueous process for prepares a pharmaceutical composition according to any one of claims 1 to 28, the process characterized in that it comprises direct mixing, dry granulation or roller compaction. Claim 38: A product characterized in that it is manufactured by the process of any one of claims 32 to 37. |
| priorityDate | 2005-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.